Agid, Y. Parkinson’s disease: Pathophysiology Lancet
337 (1991) 1321–1324.
Article
PubMed
CAS
Google Scholar
Tillerson, J.L. and Miller, G.W. Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism. J. Neurosci. Methods
123 (2003) 189–200.
Article
PubMed
Google Scholar
Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H. and Hara, H. Rifampicin attenuates the MPTP induced neurotoxicity in mouse brain. Brain Res.
1082 (2006) 196–204.
Article
PubMed
CAS
Google Scholar
Gao, Z.G., Cui, W.Y., Zhang H.T. and Liu, C.G. Effects of nicotine on 1-methyl,4-phenyl 1,2,3,6 tetrahydropyridine induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice. Pharmacol. Res.
38 (1998) 101–106.
Article
PubMed
CAS
Google Scholar
Sindhu, M.K., Saravanan, K.S. and Mohanakumar K.P. Behavioral differences in a rotenone-induced hemiparkinsonism rat model developed following intranigral or median forebrain bundle infusion. Brain Res.
1051 (2005) 25–34.
Article
PubMed
CAS
Google Scholar
Gerlach, M., Riederer, P., Przuntek, H. and Youdim, M.B.H. MPTP mechanisms of neurotoxicity and their implications for Parkinson’s disease. Eur. J. Pharmacol.
208 (1991) 273–286.
Article
PubMed
CAS
Google Scholar
Schmidt, N. and Ferger, B. Neurochemical findings in the MPTP model of Parkinson’s disease. J. Neural Transm.
108 (2001) 1263–1282.
Article
PubMed
CAS
Google Scholar
Rozas, G., Lopez-Martin, E., Guerra, M.J. and Labanderia-Garcia, J.L. The overall rod performance test in the MPTP-treated moue model of parkinsonism. J. Neurosci. Methods
83 (1998) 165–175.
Article
PubMed
CAS
Google Scholar
Muralikrishnan, D., Samantarary, S. and Mohanakumar K.P. D-deprenyl protects nigrostriatal neurons against 1-methyl 4-phenbyl 1,2,3,6-tetrahyropyridine induced dopaminergic neurotoxicity. Synapse
50 (2003) 7–13.
Article
PubMed
CAS
Google Scholar
Bhattacharya, S.K., Satyan, K.S., and Ghosal, S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J. Exp. Biol.
35 (1997) 236–239.
PubMed
CAS
Google Scholar
Panda, S. and Kar, A. Evidence for free radical scavenging activity of Ashwagandha root powder in mice. Indian J. Physiol. Pharmacol.
41 (1997) 424–426.
PubMed
CAS
Google Scholar
Raja Sankar, S., Manivasagam, T., Albert Singh, V., Krishnamurti, A. and Ramanathan, M. Prophylatic efficacy of Withania somnifera against MPTP-induced Parkinson’s disease in mice. J. Cell Tissue Res.
7 (2007) 975–979.
Google Scholar
Mohanasundari, M., Srinivasan, M.S., Sethupathy, S. and Sabesan, M. Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice. J. Neurol. Sci.
249 (2006) 140–144.
Article
PubMed
CAS
Google Scholar
Fernagut, P.O., Diguet, E., Labattu, B. and Tison, F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods
113 (2002) 123–130.
Article
PubMed
Google Scholar
Glowinski, J. and Iversen, L.L. Regional studies of cateholamines in the rat brain-I. J. Neurochem.
13 (1966) 655–669.
Article
PubMed
CAS
Google Scholar
Fraga, C.G., Leibovitz, B.E. and Tappel, A.L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic. Biol. Med.
4 (1988) 155–161.
Article
PubMed
CAS
Google Scholar
Kakkar, P., Das, B. and Viswanathan, P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys.
21 (1984) 130–132.
PubMed
CAS
Google Scholar
Sinha, A.K. Colorimetric assay of catalase. Anal. Biochem.
47 (1972) 389–394.
Article
PubMed
CAS
Google Scholar
Lowry, O.H., Rosebrough, N.J., Farr A.L. and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem.
193 (1951) 265–275.
PubMed
CAS
Google Scholar
Shimazu, S., Takahata, K., Tamashiro, A., Yoneda, F., Iida, Y. and Saji, H., Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson’s disease induced by co-administration of 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine and diethyldithiocarbamate. J. Neural Transm.
110 (2003) 871–883.
Article
PubMed
CAS
Google Scholar
Hanakawa, T., Katsumi, Y., Fukuyuma, H., Honda, M., Hayashi, T., Kimura, J. and Shibasaki, H. Mechanisms underlying gait disturbance in Parkinson’s disease: a single photon emission computed tomography study. Brain
122 (1999) 1271–1282.
Article
PubMed
Google Scholar
Ahmad, M., Saleem, S., Ahmad, A.S., Ansari, M.A., Yousuf, S., Hoda, M.N. and Islam, F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Human. Exp. Toxicol.
24 (2005) 137–147.
Article
Google Scholar
Dhanasekaran, M., Uthayathas, S., Karuppagounder, S.S., Parameshwaran, K., Suppiramaniam, V., Ebadi, M. and Brown-Borg, H.M. Ebselen effects on MPTP-induced neurotoxicity. Brain Res.
1118 (2006) 251–254.
Article
PubMed
CAS
Google Scholar
Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. and Marsden, C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J. Neurochem.
52 (1989) 381–389.
Article
PubMed
CAS
Google Scholar
Dexter, D.T., Holley, A.E., Flitter, W.D., Slater, T.F., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. and Marsden, C.D. Increased levels of lipid hydroperoxides in the parkinsonia substania nigra: an HPLC and ESR study. Mov. Disord.
9 (1994) 92–97.
Article
PubMed
CAS
Google Scholar
Chiba, K., Trevor, A. and Castagnoli, N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun.
120 (1984) 574–578.
Article
PubMed
CAS
Google Scholar
Zang, L.Y. and Misra, H.P. Generation of reactive oxygen species during the monoamine oxidase catalysed oxidation of the neurotoxicant 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine. J. Biol. Chem.
268 (1993) 16504–16512.
PubMed
CAS
Google Scholar
Rojas, P. and Rios, C. Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice. Pharmacol Toxicol.
72 (1993) 364–368.
Article
PubMed
CAS
Google Scholar
Adams, J.D. Jr., Klaidman, L.K. and Leung A.C. MPP+ and MPDP+ induced oxygen radical formation with mitchondrial enzymes. Free Radic. Biol. Med.
15 (1993) 181–186.
Article
PubMed
CAS
Google Scholar
Muralikrishnan, D. and Mohanakumar, K.P. Neuroprtotection by bromocriptine against 1-methy1 4-pheny1 1,2,3,6 tetrahydrophyridine induced neurotoxicity in mice. FASEB J.
12 (1998) 905–912
PubMed
CAS
Google Scholar
Rajeswari, A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur. Rev. Med. Pharmacol. Sci.
10 (2006) 157–161.
PubMed
CAS
Google Scholar
Devi, P.U., Sharada, A.C., Solomon, F.E. and Kamath, M.S. In vivo growth inhibitory effect of Withania somnifera on a transplantable mouse tumor, Sarcoma 180. Indian J. Exp. Biol.
30 (1992) 169–172.
PubMed
CAS
Google Scholar
Dhuley, J.N. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J. Ethnopharmacol.
70 (2000) 57–63.
Article
PubMed
CAS
Google Scholar
Russo, A., Izzo A.A., Cardile, V., Borrelli, F. and Vanella, A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine
8 (2001) 125–132.
Article
PubMed
CAS
Google Scholar
Bhattacharya, S.K., Kumar, A. and Ghosal, S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. Phytother. Res.
9 (1995)110–113.
Article
CAS
Google Scholar
Andallu, B. and Radhika, B. Hypoglycemic, and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J. Exp. Biol.
38 (2000) 607–609.
PubMed
CAS
Google Scholar
Dhuley, J.N. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother. Res.
15 (2001) 524–528.
Article
PubMed
CAS
Google Scholar